HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,350.00
-30.00 (-0.89%)
Sep 29, 2025, 3:30 PM KST

HLB Life Science Revenue

HLB Life Science had revenue of 11.77B KRW in the quarter ending June 30, 2025, with 57.39% growth. This brings the company's revenue in the last twelve months to 108.93B, up 81.79% year-over-year. In the year 2024, HLB Life Science had annual revenue of 102.24B with 4.34% growth.

Revenue (ttm)
108.93B
Revenue Growth
+81.79%
P/S Ratio
3.78
Revenue / Employee
711.93M
Employees
153
Market Cap
411.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.24B4.25B4.34%
Dec 31, 202397.99B-1.60B-1.61%
Dec 31, 202299.59B46.10B86.17%
Dec 31, 202153.49B-38.30B-41.73%
Dec 31, 202091.80B-22.22B-19.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Korea Electric Power 95.81T
Korea Gas 38.45T
Korea District Heating 3,863.29B
SK eternix 471.03B
Samchully Co.,Ltd 5,288.36B
Korea Electric Power Industrial Development 375.42B
INVENI 1,282.69B
Seoul City Gas 1,819.00B
Revenue Rankings